We are live on
!
Find out more
Two Sigma Investments Portfolio holdings
AUM
$124B
1-Year Est. Return
33.93%
This Fund
S&P 500
This Quarter
Est. Return
+9.67%
1 Year Est. Return
+33.93%
3 Year Est. Return
+96.56%
5 Year Est. Return
+105.93%
10 Year Est. Return
+538.88%
AUM
$42.6B
AUM Growth
-$927M
(-2.1%)
Cap. Flow
-$4.42B
Cap. Flow
% of AUM
-10.38%
Top 10 Holdings %
Top 10 Hldgs %
9.02%
Holding
3,518
New
408
Increased
1,022
Reduced
1,392
Closed
532
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$244M |
| 2 |
Pfizer
PFE
|
+$234M |
| 3 |
Nike
NKE
|
+$201M |
| 4 |
Tesla
TSLA
|
+$200M |
| 5 |
S&P Global
SPGI
|
+$196M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$305M |
| 2 |
Advanced Micro Devices
AMD
|
+$241M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$231M |
| 4 |
Merck
MRK
|
+$199M |
| 5 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$190M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.1% |
| 2 | Healthcare | 11.63% |
| 3 | Consumer Discretionary | 11.09% |
| 4 | Financials | 10.76% |
| 5 | Industrials | 9.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2201
Cars.com
CARS
$660M
| $610K | ﹤0.01% |
+35,485
| New | +$633K |
|
2202
Donegal Group Class A
DGICA
$714M
| $607K | ﹤0.01% |
42,957
+11,377
| +36% | +$161K |
|
2203
iShares US Basic Materials ETF
IYM
$1.02B
| $606K | ﹤0.01% |
+4,100
| New | +$563K |
|
|
IMOS
2204
ChipMOS TECHNOLOGIES
IMOS
$1.83B
| $605K | ﹤0.01% |
19,228
-2,330
| -11% | -$66.3K |
|
2205
Saic
SAIC
$5.35B
| $603K | ﹤0.01% |
4,626
+2,141
| +86% | +$283K |
|
2206
Evercore
EVR
$11.8B
| $603K | ﹤0.01% |
3,130
-8,970
| -74% | -$1.62M |
|
2207
Invivyd
IVVD
$218M
| $603K | ﹤0.01% |
135,761
+78,907
| +139% | +$326K |
|
2208
HUTCHMED
HCM
$2.17B
| $602K | ﹤0.01% |
35,830
+17,830
| +99% | +$271K |
|
2209
PC Connection
CNXN
$2.12B
| $601K | ﹤0.01% |
9,120
+400
| +5% | +$26.2K |
|
2210
Xerox
XRX
$425M
| $600K | ﹤0.01% |
33,528
-69,045
| -67% | -$1.21M |
|
2211
Cavco Industries
CVCO
$4.55B
| $599K | ﹤0.01% |
1,500
-500
| -25% | -$177K |
|
2212
PROG Holdings
PRG
$1.71B
| $597K | ﹤0.01% |
17,344
+4,792
| +38% | +$151K |
|
2213
Ultrapar
UGP
$6.54B
| $596K | ﹤0.01% |
104,200
-119,300
| -53% | -$689K |
|
|
GRSD
2214
Grandstand Limited Ordinary Shares
GRSD
$67M
| $596K | ﹤0.01% |
65,228
-25,924
| -28% | -$235K |
|
2215
Dimensional US Targeted Value ETF
DFAT
$14.7B
| $593K | ﹤0.01% |
10,900
-18,500
| -63% | -$952K |
|
2216
Invesco S&P SmallCap Low Volatility ETF
XSLV
$249M
| $592K | ﹤0.01% |
13,400
-9,000
| -40% | -$389K |
|
2217
NetEase
NTES
$84.7B
| $590K | ﹤0.01% |
5,700
-15,100
| -73% | -$1.54M |
|
2218
Colony Bankcorp
CBAN
$467M
| $589K | ﹤0.01% |
51,251
-2,571
| -5% | -$30.3K |
|
2219
EnerSys
ENS
$6.99B
| $586K | ﹤0.01% |
+6,200
| New | +$583K |
|
2220
Evolv Technologies
EVLV
$1.1B
| $585K | ﹤0.01% |
131,564
-474,743
| -78% | -$2.05M |
|
2221
Invesco Russell 2000 Dynamic Multifactor ETF
OMFS
$287M
| $582K | ﹤0.01% |
15,400
+5,900
| +62% | +$216K |
|
|
AMED
2222
DELISTED
Amedisys
AMED
| $581K | ﹤0.01% |
6,300
-13,840
| -69% | -$1.3M |
|
2223
Stride
LRN
$3.43B
| $580K | ﹤0.01% |
9,204
-158,723
| -95% | -$9.57M |
|
2224
OrthoPediatrics
KIDS
$595M
| $580K | ﹤0.01% |
+19,899
| New | +$556K |
|
2225
Aehr Test Systems
AEHR
$3.36B
| $580K | ﹤0.01% |
+46,793
| New | +$780K |
|
Similar funds
VAM
Two Sigma Investments's Q1 2024 Portfolio in Review
As of Q1 2024, Two Sigma Investments held 3,518 positions worth $42.6B, down 2.1% from $43.5B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
Two Sigma Investments withdrew a net $4.42B in Q1 2024, closing 532 positions and reducing 1,392 holdings. Its most notable exit was Rivian, an estimated $158M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 18% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Two Sigma Investments opened a new position in Pfizer worth $234M.
- Two Sigma Investments's largest Q1 2024 buy was Pfizer: 8,419,014 shares worth $234M.
- Two Sigma Investments added most to Gilead Sciences in Q1 2024, an estimated $244M increase.
- Two Sigma Investments's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $305M.
- Two Sigma Investments fully exited Rivian in Q1 2024, selling an estimated $158M.
- Two Sigma Investments's ten largest holdings make up 9% of its $42.6B portfolio in Q1 2024.
- Two Sigma Investments opened 408 new positions and closed 532 in Q1 2024.
- Two Sigma Investments's portfolio value fell 2.1% quarter-over-quarter to $42.6B.
Based on Two Sigma Investments's 13F filing for Q1 2024, filed 15 May 2024.